Clinical Trial Update: Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dabrafenib with or without trametinib in advanced differentiated thyroid carcinoma, including follicular, papillary, insular, and recur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma
• Follicular Thyroid Carcinoma
• Insular Thyroid Carcinoma
• Papillary Thyroid Carcinoma
• Thyroid Carcinoma

Drugs mentioned

• MEKINIST (trametinib)
• TAFINLAR (DABRAFENIB)

Snippet

Sponsor: Bhavana Konda | Conditions: Follicular Thyroid Cancer, Insular Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-08-24